Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4637.00 | 4493.25 | 1.0320 | 1.0717 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4149.00 | 4493.25 | 0.9234 | 0.8293 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 4537.00 | 4493.25 | 1.0097 | 1.0218 |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4627.00 | 4493.25 | 1.0298 | 1.0667 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4454.00 | 4493.25 | 0.9913 | 0.9805 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4216.00 | 4493.25 | 0.9383 | 0.8624 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5598.00 | 5883.75 | 0.9514 | 0.8176 | |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5761.00 | 5883.75 | 0.9791 | 0.9206 | |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 5000.00 | 4101.40 | 2211.00 | 5883.75 | 0.3758 | -0.6948 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5686.00 | 5883.75 | 0.9664 | 0.8729 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5445.00 | 5883.75 | 0.9254 | 0.7234 |
| SK-BR-3 | 0 | uM | 3 | 5000.00 | 4101.40 | 5941.00 | 5883.75 | 1.0097 | 1.0375 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5761.00 | 5883.75 | 0.9791 | 0.9206 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 4165.00 | 5883.75 | 0.7079 | 0.0300 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 3882.00 | 5883.75 | 0.6598 | -0.1002 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 6098.00 | 5883.75 | 1.0364 | 1.1422 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 5000.00 | 4101.40 | 6065.00 | 5883.75 | 1.0308 | 1.1200 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5790.00 | 5883.75 | 0.9841 | 0.9392 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 5000.00 | 4101.40 | 5882.00 | 5883.75 | 0.9997 | 0.9989 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 2747.00 | 5883.75 | 0.4669 | -0.5369 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 5000.00 | 4101.40 | 2579.00 | 5883.75 | 0.4383 | -0.5898 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5995.00 | 5883.75 | 1.0189 | 1.0733 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 5000.00 | 4101.40 | 5924.00 | 5883.75 | 1.0068 | 1.0264 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 5000.00 | 4101.40 | 5859.00 | 5883.75 | 0.9958 | 0.9839 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 5000.00 | 4101.40 | 6043.00 | 5883.75 | 1.0271 | 1.1053 |